Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.
D000293:Adolescent; D001996:Bronchopneumonia / Q000150:complications; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000008:administration & dosage; D003023:Cloxacillin / Q000008:administration & dosage; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005260:Female; D005672:Fusidic Acid / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D008034:Lincomycin / Q000008:administration & dosage*; D008297:Male; D009355:Neomycin / Q000008:administration & dosage; D009675:Novobiocin / Q000008:administration & dosage; D010403:Penicillin Resistance; D010404:Penicillin V / Q000008:administration & dosage; D011552:Pseudomonas Infections / Q000150:complications; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013752:Tetracycline / Q000008:administration & dosage
D009675:Novobiocin; D005672:Fusidic Acid; D002701:Chloramphenicol; D008034:Lincomycin; D013752:Tetracycline; D009355:Neomycin; D003023:Cloxacillin; D010404:Penicillin V